Application of Electromagnetic Navigation System in Pulmonary Nodule Localization (NCT07595120) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Application of Electromagnetic Navigation System in Pulmonary Nodule Localization
China400 participantsStarted 2026-05
Plain-language summary
This study aims to design and conduct a multicenter, prospective, randomized controlled post-market clinical trial to validate the clinical efficacy of high-precision electromagnetic navigation technology.
Who can participate
Age range
18 Years – 80 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Age 18-80 years, regardless of gender;
. Solitary single nodule, scheduled for lung nodule puncture and localization;
. Chest CT (lung window mode) showing a maximum nodule diameter ≤ 2 cm;
. Eastern Cooperative Oncology Group (ECOG) performance status score 0-2;
. Voluntary participation, with signed informed consent.
Exclusion criteria
. Not suitable for video-assisted thoracoscopic surgery;
. The distance between the center of the lesion and the dome of the diaphragm is \< 3 cm;
. History of thoracic adhesion due to previous thoracotomy or pleural infection;
. Patients judged by the investigator to be unsuitable for preoperative transthoracic or transbronchial localization;
. Inability to complete follow-up or poor compliance.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Success rate of intraoperative localization of lung nodules
Timeframe: Day 0 (Intraoperative)
Trial details
NCT IDNCT07595120
SponsorShanghai Pulmonary Hospital, Shanghai, China